Are products with an orphan designation for oncology indications different from products for other rare indications? A retrospective analysis of European orphan designations granted between 2002-2012
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1172
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Are products with an orphan designation for oncology indications different from products for other rare indications? A retrospective analysis of European orphan designations granted between 2002-2012 ; volume:12 ; number:1 ; day:16 ; month:2 ; year:2017 ; pages:1-7 ; date:12.2017
Orphanet journal of rare diseases ; 12, Heft 1 (16.2.2017), 1-7, 12.2017
- Schlagwort
-
Arzneimittelentwicklung
Arzneimitteldesign
- Urheber
-
Pauwels, Kim
- Beteiligte Personen und Organisationen
-
Huys, Isabelle
Casteels, Minne
Larsson, Kristina
Voltz, Caroline
Penttila, Karri
Morel, Thomas
Simoens, Steven
SpringerLink (Online service)
- DOI
-
10.1186/s13023-017-0578-4
- URN
-
urn:nbn:de:1111-2017031012819
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pauwels, Kim
- Huys, Isabelle
- Casteels, Minne
- Larsson, Kristina
- Voltz, Caroline
- Penttila, Karri
- Morel, Thomas
- Simoens, Steven
- SpringerLink (Online service)
Ähnliche Objekte (12)
Clinical evidence for orphan medicinal products-a cause for concern?
Comparing access to orphan medicinal products in Europe
The European challenges of funding orphan medicinal products
Establishment of a value assessment framework for orphan medicinal products in China
10th European Conference on Rare Diseases & Orphan Products (ECRD 2020)
Off-label use of orphan medicinal products: a Belgian qualitative study
Costs of orphan medicinal products: longitudinal analysis of expenditure in Wales
Geographic Indications as flagship products for sustainable landscape management in the European Union
The Orphan
Orphan Island
No difference in between-country variability in use of newly approved orphan and non- orphan medicinal products - a pilot study
Indications
Clinical evidence for orphan medicinal products-a cause for concern?
Comparing access to orphan medicinal products in Europe
The European challenges of funding orphan medicinal products
Establishment of a value assessment framework for orphan medicinal products in China
10th European Conference on Rare Diseases & Orphan Products (ECRD 2020)
Off-label use of orphan medicinal products: a Belgian qualitative study
Costs of orphan medicinal products: longitudinal analysis of expenditure in Wales
Geographic Indications as flagship products for sustainable landscape management in the European Union
The Orphan
Orphan Island
No difference in between-country variability in use of newly approved orphan and non- orphan medicinal products - a pilot study
Indications
Clinical evidence for orphan medicinal products-a cause for concern?
Comparing access to orphan medicinal products in Europe
The European challenges of funding orphan medicinal products
Establishment of a value assessment framework for orphan medicinal products in China
10th European Conference on Rare Diseases & Orphan Products (ECRD 2020)
Off-label use of orphan medicinal products: a Belgian qualitative study
Costs of orphan medicinal products: longitudinal analysis of expenditure in Wales
Geographic Indications as flagship products for sustainable landscape management in the European Union
The Orphan
Orphan Island
No difference in between-country variability in use of newly approved orphan and non- orphan medicinal products - a pilot study